Skip to main content
Signal8

Spruce Street Capital LP

Spruce Street Capital LP is an Investment Adviser institutional filer with the SEC under CIK 2050194, reporting 30 portfolio positions, with 8 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-13

Top 10 portfolio positions

The largest reported holdings in Spruce Street Capital LP's most recent 13F filing, ranked by reported market value.

  1. KINIKSA PHARMACEUTICALS INTL (KNSA)
  2. RELAY THERAPEUTICS INC (RLAY)
  3. LB PHARMACEUTICALS INC (LBRX)
  4. RELMADA THERAPEUTICS INC (RLMD)
  5. ALTO NEUROSCIENCE INC (ANRO)
  6. DIANTHUS THERAPEUTICS INC (DNTH)
  7. ALKERMES PLC (ALKS)
  8. SAVARA INC (SVRA)
  9. VAXCYTE INC (PCVX)
  10. ENLIVEN THERAPEUTICS INC (ELVN)
/